The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Open accessAbstract
CONTEXT: Adrenal tumors have a prevalence of around 2% in the general population. Adrenocortical carcinoma (ACC) is rare but accounts for 2-11% of incidentally discovered adrenal masses. Differentiating ACC from adrenocortical adenoma (ACA) represents a diagnostic challenge in patients with adrenal incidentalomas, with tumor size, imaging, and even histology all providing unsatisfactory predictive values. OBJECTIVE: Here we developed a novel steroid metabolomic approach, mass spectrometry-based steroid profiling followed by machine learning analysis, and examined its diagnostic value for the detection of adrenal malignancy. DESIGN: Quantification of 32 distinct adrenal derived steroids was carried out by gas chromatography/mass spectrometry in 24-h urine samples from 102 ACA patients (age range 19-84 yr) and 45 ACC patients (20-80 yr). Underlying diagnosis was ascertained by histology and metastasis in ACC and by clinical follow-up [median duration 52 (range 26-201) months] without evidence of metastasis in ACA. Steroid excretion data were subjected to generalized matrix learning vector quantization (GMLVQ) to identify the most discriminative steroids. RESULTS: Steroid profiling revealed a pattern of predominantly immature, early-stage steroidogenesis in ACC. GMLVQ analysis identified a subset of nine steroids that performed best in differentiating ACA from ACC. Receiver-operating characteristics analysis of GMLVQ results demonstrated sensitivity = specificity = 90% (area under the curve = 0.97) employing all 32 steroids and sensitivity = specificity = 88% (area under the curve = 0.96) when using only the nine most differentiating markers. CONCLUSIONS: Urine steroid metabolomics is a novel, highly sensitive, and specific biomarker tool for discriminating benign from malignant adrenal tumors, with obvious promise for the diagnostic work-up of patients with adrenal incidentalomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenal steroid production and metabolism are affected by sex, age, and BMI (342,345,346).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Twenty-four-hour urine steroid excretion analysis represents a more accurate estimate of total corticosteroid production and of adrenal precursor steroids and metabolites (342, 343) and therefore has significant potential in the assessment of adrenal diseases.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Twenty-four-hour urine steroid excretion analysis represents a more accurate estimate of total corticosteroid production and of adrenal precursor steroids and metabolites (342, 343) and therefore has significant potential in the assessment of adrenal diseases.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“In particular, the cosecretion of a distinct combination of glucocorticoid and androgen metabolites is emerging as a sensitive diagnostic tool for ACC (342,348,349).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“The majority of ACC patients (69%) showed androgen precursor excess, either combined with increased excretion of glucocorticoid precursors (36%) or both glucocorticoid and mineralocorticoid precursors (33%).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Using machine learning, the authors were able to identify that tetrahydro-11-deoxycortisol (THS), pregnenetriol (5-PT), and pregnenediol (5-PD) were the most discriminatory between ACC and ACA.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Urinary steroid profiling revealed distinct differences between adrenocortical adenomas and ACC patients (Fig. 10).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“There was no effect of age, sex, tumor size, or presence of metastasis on the characteristics of the urine steroid metabolomes in ACC and ACA patients.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Studies have shown that ACCs have a distinct pattern of urinary corticosteroids, characterized by an excess of precursor steroid metabolites (Fig. 10 (342)).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Even when analyzing the ACC patients without evidence of hormone excess on routine biochemistry, urinary excretion of androgen, and glucocorticoid precursor metabolites remained significantly increased.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“They reported that 27% of patients with ACC had no hormonal excess on routine biochemical testing.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“By contrast, steroid precursor metabolite excretion in nonmalignant AI did not differ from healthy controls.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“ACC patients had a significantly higher excretion of androgen precursor metabolites, metabolites of active androgens, deoxycorticosterone, and glucocorticoid precursor metabolites were significantly higher in ACC, as was free cortisol.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“All studies identified THS as the most informative steroid marker indicative of ACC.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Particularly, the reoccurrence of presurgical steroid profiles may raise concern of relapse (95).”
From Adrenocortical carcinoma (2014) · cites this paper as [95]
In the citing paper
“As an example, this approach has been used for automating differentiation of adrenocortical carcinoma (ACC) from benign adrenocortical tumors based on the detection of a “malignant steroid fingerprint”, a distinct set of urine steroid metabolites characteristically increased in ACC [348].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [348]
In the citing paper
“The urinary steroid metabolome represents the total of all steroid biosynthetic and metabolising pathways and has proven to be a specific and sensitive biomarker for the diagnosis of steroidogenic disease (Arlt et al., 2011).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Arlt et al., 2011
In the citing paper
“AST and ETIO are measured as representatives of active androgens, while DHEA and 16αOH-DHEA are measured as representatives of direct androgen precursors (Arlt et al., 2011, Krone et al., 2010).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Arlt et al., 2011
In the citing paper
“The combination of mass spectrometry–based steroid profiling with machine learning–based data analysis has created a powerful discovery tool, steroid metabolomics, highly suited as a diagnostic biomarker approach (1–4).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“The combination of mass spectrometry–based steroid profiling with machine learning–driven analysis of the urinary steroid excretion data allowed for rapid detection of a “malignant steroid fingerprint” (Fig. 8E) (1) that can differentiate ACC from ACA with high sensitivity and specificity.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“The steroid biomarkers that are most helpful at distinguishing ACCs from ACAs include the glucocorticoid precursor metabolite THS, and the androgen precursor metabolites of Preg and 17OHPreg, 5PD, and 5PT (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Additionally, recent retrospective studies employing GC-MS–based urine steroid profiling revealed that ACCs present a unique steroidogenic “signature” characterized by accumulation of steroid hormone precursors (1, 154, 155) (Fig. 8E).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Isolated autonomous androgen excess from the adrenal gland can very rarely occur in the context of benign ACAs (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Routine serum biochemistry detects steroid hormone excess in 60% to 70% of ACC patients, with glucocorticoid and androgen excess dominating (1, 188); however, urine GC-MS profiling demonstrated steroid excess in >90% (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Routine serum biochemistry detects steroid hormone excess in 60% to 70% of ACC patients, with glucocorticoid and androgen excess dominating (1, 188); however, urine GC-MS profiling demonstrated steroid excess in >90% (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Springer eBooks · doi:10.1007/0-387-27255-0_9 · Cited by 20,333
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Kohonen, T. (1995) · Springer series in information sciences · doi:10.1007/978-3-642-56927-2 · Cited by 16,032
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 4×
“The risk of malignancy increases with the diameter of the adrenal mass (1, 2, 8).”
BackgroundMethodInfluentialA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationPathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818 · cited 2×
“a The Weiss system scores the presence or absence of nine histopathological features (Weiss score range 0–9); scores under 3 are indicative of a benign adrenal tumor, scores of 3 are borderline, and scores of 4 and above are indicative of malignancy (14).”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Self-citationFassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Shackleton, 2011, GC/MS steroid profiling: diagnosis of disorders affecting steroid synthesis and metabolism, 789
Cited by
Sorted by citations
Items 201–300 of 458
Next Generation Sequencing for Disorders of Sex Development
Tobias, E. S., & McElreavey, K. (2014) · Endocrine development · doi:10.1159/000363615 · Cited by 16
Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study
Yu, K., Athimulam, S., Saini, J., Kaur, R. J., Xue, Q., McKenzie, T. J., Singh, R. J., Grebe, S. K. G., & Bancos, I. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae604 · Cited by 15
Metabolomics: Approaches and Applications to Diabetes Research
Preet, A. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s6-001 · Cited by 16
Personalized Care of Patients with Adrenocortical Carcinoma: A Comprehensive Approach
Miller, B. S., & Else, T. (2017) · Endocrine Practice · doi:10.4158/ep161719.ra · Cited by 15
Castro, M. A., Casals, G., Hanzu, F. A., Corrales, E. P., Cano, A. M. G., Lanza, V. F., del Rey-Mejías, Á. L., Pinedo, M. M., Escobar-Morreale, H. F., & Valderrábano, P. (2022) · Clinical Endocrinology · doi:10.1111/cen.14811 · Cited by 15
Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas
Hofland, J., Feelders, R. A., van der Wal, R., Kerstens, M. N., Haak, H. R., de Herder, W. W., & de Jong, F. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0693 · Cited by 15
Великанова, Л. И., Геннадьевна, С. Е., Obedkova, E. V., Krivokhizhina, N. S., Ривгатовна, Ш. З., Grigoryan, K., Povarov, V. G., & Москвин, А. Л. (2016) · Journal of Analytical Chemistry · doi:10.1134/s1061934816070169 · Cited by 15
Novel methods in adrenal research: a metabolomics approach
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01772-w · Cited by 14
Self-citationRecent Advances and Challenges in Steroid Metabolomics for Biomarker Discovery
Kotłowska, A., & Szefer, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171113120810 · Cited by 14
Using CT radiomic features based on machine learning models to subtype adrenal adenoma
Qi, S., Zuo, Y., Chang, R., Huang, K., Liu, J., & Zhang, Z. (2023) · BMC Cancer · doi:10.1186/s12885-023-10562-6 · Cited by 14
Presentation and management of patients with adrenal masses: a large tertiary centre experience
Suntornlohanakul, O., Mandal, S., Saha, P., Saygılı, E. S., Asia, M. F., Arlt, W., Elhassan, Y., Prete, A., & Ronchi, C. L. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae131 · Cited by 14
Self-citationBoareto, M., Cesar, J. E. D. S., Leite, V. B. P., & Caticha, N. (2014) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2377750 · Cited by 14
Lee, W., Lee, H., Kim, Y. L., Lee, Y. C., Chung, B. C., & Hong, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041872 · Cited by 14
Yang, H., He, Q., Eremin, S. A., Pan, J., Zou, Y., Cui, X., & Zhao, S. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03403-7 · Cited by 14
Tõke, J., Uhlyarik, A., Lohinszky, J., Stark, J., Huszty, G., Micsík, T., Borka, K., Reismann, P., Horányi, J., Igaz, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.952418 · Cited by 14
Ривгатовна, Ш. З., Великанова, Л. И., Ворохобина, Н. В., Борисович, Ш. С., Lisitsin, A. A., Валерьевна, М. Е., Buinova, M. O., Бессонова, Е. А., & Kirsanov, D. O. (2018) · Steroids · doi:10.1016/j.steroids.2018.04.006 · Cited by 14
Open versus minimally invasive surgery for suspected adrenocortical carcinoma
Buller, D. M., Hennessey, A. M., & Ristau, B. T. (2021) · Translational Andrology and Urology · doi:10.21037/tau.2020.01.11 · Cited by 15
Application of Steroid Hormone Metabolomics in Search of Biomarkers in Clinical Research
Kotłowska, A. (2012) · Drug Development Research · doi:10.1002/ddr.21028 · Cited by 14
Regularization and improved interpretation of linear data mappings and adaptive distance measures
Marc Strickert, A., Hammer, B., Villmann, T., & Biehl, M. L. (2013) · IEEE Symposium on Computational Intelligence and Data Mining (CIDM) · doi:10.1109/cidm.2013.6597211 · Cited by 13
Self-citationThe dynamics of a serum steroid profile after stimulation with intravenous ACTH
Lindner, J. M., Suhr, A. C., Grimm, S., Möhnle, P., Vogeser, M., & Briegel, J. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.12.045 · Cited by 13
Primary adrenal leiomyosarcoma with inferior vena cava extension in a 70-year-old man
Doppalapudi, S. K., Shah, T., Fitzhugh, V. A., & Bargman, V. G. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-227670 · Cited by 13
Link between steroidogenesis, the cell cycle, and PKA in adrenocortical tumor cells
Rizk‐Rabin, M., Chaoui-Ibadioune, S., Vaczlavik, A., Ribes, C., Polak, M., Ragazzon, B., & Bertherat, J. Y. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110636 · Cited by 13
Self-citationThomson, W., Jabbari, S., TAYLOR, A. E. R., Arlt, W., & Smith, D. J. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2018.0572 · Cited by 13
Self-citationEisenhofer, G., Durán, C., Chavakis, T., & Cannistraci, C. V. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.07.002 · Cited by 13
Application of Chemometric Techniques in Search of Clinically Applicable Biomarkers of Disease
Kotłowska, A. (2014) · Drug Development Research · doi:10.1002/ddr.21213 · Cited by 13
Szatko, A., Toboła, A., Falhammar, H., Zgliczyński, W., & Glinicki, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1548344 · Cited by 12
Великанова, Л. И., Ривгатовна, Ш. З., Ворохобина, Н. В., & Валерьевна, М. Е. (2019) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-019-04597-8 · Cited by 12
A Feminizing Adrenocortical Carcinoma in the Context of a Late Onset 21-Hydroxylase Deficiency
Libé, R., Arlt, W., Louiset, E., Waintrop, C., Guibourdenche, J., Sibony, M., Clauser, É., & Groussin, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1342 · Cited by 12
Self-citationAdrenal incidentaloma: differential diagnosis and management strategies
Morelli, V., & Palmieri, S. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02868-7 · Cited by 12
Vogg, N., Müller, T., Floren, A., Dandekar, T., Scherf‐Clavel, O., Faßnacht, M., Kroiß, M., & Kurlbaum, M. (2022) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2022.07.006 · Cited by 12
Zalas, D., Reinehr, T., Niedziela, M., Borzikowsky, C., Flader, M., Ŝimić-Schleicher, G., Akkurt, H. I., Heger, S., Hornig, N., Holterhus, P., et al. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488028 · Cited by 13
Martins, R. G., Gonçalves, L. G., Cunha, N., & Bugalho, M. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01101 · Cited by 11
Near-Infrared Dye-Aptamer Assay for Small Molecule Detection in Complex Specimens
Jin, X., Liu, Y., Alkhamis, O., Canoura, J., Bacon, A., Xu, R., Fu, F., & Xiao, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01095 · Cited by 11
Laparoscopic adrenalectomy for adrenocortical carcinoma: A medico-surgical perspective
Gaujoux, S., Bertherat, J. Y., Dousset, B. E., & Groussin, L. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.07.001 · Cited by 11
Self-citationUrine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
SCHTEINGART, D. E. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.05.017 · Cited by 11
Napier, C., Allinson, K. R., Gan, E. H., Mitchell, A. L., Gilligan, L. C., TAYLOR, A. E. R., Arlt, W., & Pearce, S. H. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa187 · Cited by 11
Self-citationBiomedical Applications of Prototype Based Classifiers and Relevance Learning
Biehl, M. L. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-58163-7_1 · Cited by 11
Self-citationSteroid Profiling for Adrenocortical Disorders: A Pathway for Omics-Based Diagnostics
Eisenhofer, G., & Faßnacht, M. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.281048 · Cited by 11
Kimpel, O., Altieri, B., Dischinger, U., Fuß, C. T., Kurlbaum, M., & Faßnacht, M. (2023) · Metabolites · doi:10.3390/metabo14010020 · Cited by 10
Effective and mild method for converting 3β-hydroxysteroids to 3-keto steroids via DDQ/TEMPO
Zhang, W., Pan, D., Wu, A., & Shen, L. (2015) · Steroids · doi:10.1016/j.steroids.2015.01.010 · Cited by 10
Adrenocortical Carcinoma: Modern Management and Evolving Treatment Strategies
McDuffie, L. A., & Aufforth, R. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije-2015-0003 · Cited by 10
Dried urine and salivary profiling for complete assessment of cortisol and cortisol metabolites
Newman, M. S., Curran, D. A., & Mayfield, B. P. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100243 · Cited by 11
Approach to the Patient with an Incidental Adrenal Mass
He, X., Peter, P. R., & Auchus, R. J. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.009 · Cited by 11
Valid interpretation of feature relevance for linear data mappings
Frénay, B., Hofmann, D., Schulz, A., Biehl, M. L., & Hammer, B. (2014) · IEEE Symposium on Computational Intelligence and Data Mining (CIDM) · doi:10.1109/cidm.2014.7008661 · Cited by 10
Self-citationApplying mass spectrometric methods to study androgen biosynthesis and metabolism in prostate cancer
Knuuttila, M., Hämäläinen, E. K., & POUTANEN, M. H. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0150 · Cited by 10
Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies
Kuhlen, M., Schmutz, M., Kunstreich, M., Redlich, A., & Claus, R. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102942 · Cited by 9
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion
Prete, A., Abdi, L., Canducci, M., van den Brandhof, E. L., Albors-Zumel, A., Jenkinson, C., Gilligan, L. C., Zhang, Y., Visser, L., Chortis, V., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106126 · Cited by 9
Self-citationKartsova, L. A., & Obedkova, E. V. (2013) · Journal of Analytical Chemistry · doi:10.1134/s1061934813040035 · Cited by 9
Urinary steroid profiling: a powerful method for the diagnosis of abnormal steroidogenesis
Koyama, Y., Homma, K., & Hasegawa, T. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.904199 · Cited by 9
Marti, N., Malíková, J., Galván, J. A., Aebischer, M. C., Janner, M., Šumnı́k, Z., Obermannová, B., Escher, G., Perren, A. A., & Flück, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.014 · Cited by 9
Dineen, R., Behan, L., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Keevil, B. G., Tormey, W. P., Smith, D., Thompson, C. J., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00633-1 · Cited by 9
Self-citationWeng, Y., Tang, J., Zhang, X., Lin, D., Guo, Y., Liang, Y., Wang, L., Zhou, J., Li, Y., Lin, T.-X., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1435102 · Cited by 8
Subspace corrected relevance learning with application in neuroimaging
van Veen, R., Tamboli, N. R. B., Lövdal, S., Meles, S. K., Renken, R. J., de Vries, G.-J., Arnaldi, D., Morbelli, S. D., Clavero, P., Obeso, J. A., et al. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.102786 · Cited by 8
Self-citationNovel methodologies in analysis of small molecule biomarkers and living cells
Chen, Y., Zhu, Z., & Yu, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2439-2 · Cited by 8
Gagnon, N., Boily, P., Alguire, C., Corbeil, G., Bancos, I., Latour, M., Beauregard, C., Caceres, K., Haffaf, Z. E., Fred Saad, C., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02209-4 · Cited by 8
Altered cortisol metabolism in individuals with HNF1A‐MODY
Juszczak, A., Gilligan, L. C., Hughes, B. A., Hassan-Smith, Z. K., McCarthy, M. I., Arlt, W., Tomlinson, J., & Owen, K. R. (2020) · Clinical Endocrinology · doi:10.1111/cen.14218 · Cited by 9
Self-citationCorticosurrénalome : nouveautés en 2014
Libé, R., & Assié, G. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.009 · Cited by 8
Self-citationHonour, J. W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109502 · Cited by 7
Spanish consensus on the diagnosis and management of adrenocortical carcinoma
Castro, M. A., Álvarez-Escolá, C., Casteràs, A., Carmona‐Bayonas, A., Chiara, M., Hanzu, F. A., Hernando, J., Vercher-Conejero, J. L., Rodríguez‐Fraile, M., Santos, V. G. D., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-25-0034 · Cited by 7
Wang, R., Solomon, B., Luen, S. J., Prall, O. W. J., Khoo, C., Gill, A. J., Lewin, J. H., & Sachithanandan, N. (2022) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0081 · Cited by 7
Libé, R., Haissaguerre, M., Renaudin, K., Faron, M., Decaussin‐Petrucci, M., Deschamps, F., Gimenez‐Roqueplo, A., Mirallié, É., Murez, T., Pattou, F. N., et al. (2023) · Bulletin du Cancer · doi:10.1016/j.bulcan.2023.03.015 · Cited by 7
Self-citationMu, D., Xia, Q., Ma, Y., Wang, X., Gao, Y., Ma, X., Xie, S., Hou, L., Zhang, Q., Zhao, F., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.04.008 · Cited by 9
Generic probabilistic prototype based classification of vectorial and proximity data
Schleif, F.-M. (2014) · Neurocomputing · doi:10.1016/j.neucom.2014.12.002 · Cited by 7
Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass
Lenders, N. F., & Greenfield, J. R. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0090 · Cited by 7
Admire LVQ—Adaptive Distance Measures in Relevance Learning Vector Quantization
Biehl, M. L. (2012) · Künstliche Intell. · doi:10.1007/s13218-012-0188-1 · Cited by 7
Self-citationLearning Vector Quantization with Adaptive Cost-Based Outlier-Rejection
Villmann, T., Kaden, M., Nebel, D., & Biehl, M. L. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-23117-4_66 · Cited by 7
Self-citationDiagnosis and Management of Hereditary Adrenal Cancer
Angelousi, A. G., Zilbermint, M. F., Berthon, A. S., Espiard, S., & Stratakis, C. A. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-29998-3_8 · Cited by 7
Weigel, M., Hahner, S., Sherlock, M., Agha, A., Behan, L., Stewart, P. M., Arlt, W., Beier, D., Frey, K. R., Zopf, K., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13302 · Cited by 7
Self-citationThe IGF2 methylation score for adrenocortical cancer: an ENSAT validation study
Creemers, S. G., Feelders, R. A., Valdés, N., Ronchi, C. L., Volante, M., van Hemel, B. M., Luconi, M., Ettaieb, M. H. T., Mannelli, M., Chiara, M., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0378 · Cited by 7
Snaterse, G., van Dessel, L. F., TAYLOR, A. E. R., Visser, J. A., Arlt, W., Lolkema, M. P., & Hofland, J. (2021) · Steroids · doi:10.1016/j.steroids.2021.108800 · Cited by 7
Self-citationVogg, N., North, E., Gessner, A., Fels, F., Heinrich, M. R., Kroiß, M., Kurlbaum, M., Faßnacht, M., & Fromm, M. F. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-1337 · Cited by 6
Kim, J. H., Jang, H. N., Park, S. S., Yoon, J. H., Cho, Y. M., Park, S. J., Lee, J. M., & Yoon, J. W. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae167 · Cited by 6
LC-MS/MS the First 20 years: A Personal View
Keevil, B. G. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211040059 · Cited by 6
Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma
Feely, S., Mullen, N., Donlon, P. T., Reidy, E., Challapalli, R. S., Hassany, M., Sorushanova, A., Martínez, E. R., Owens, P., Quinn, A. M., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae159 · Cited by 6
Proteome analysis of adrenal cortical tumors
Kim, H. M., Lee, Y. K., & Koo, J. S. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1210008 · Cited by 6
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma
Mangone, A., Altieri, B., Detomas, M., Prete, A., Abbas, H., Asia, M. F., Elhassan, Y., Mantovani, G., & Ronchi, C. L. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0372 · Cited by 6
Tumores adrenocorticais na criança: da abordagem clínica à avaliação molecular
Antonini, S. R. R., Colli, L. M., Ferro, L., Mermejo, L. M., & de Castro, M. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800014 · Cited by 6
Ривгатовна, Ш. З., Великанова, Л. И., Vorohobina, N. V., Lisitsyn, A. A., Кухианидзе, Е. А., Геннадьевна, С. Е., Povarov, V. G., & Talor, N. F. (2015) · Problems of Endocrinology · doi:10.14341/probl20156144-8 · Cited by 6
Mass spectrometry and its evolving role in assessing tissue specific steroid metabolism
Andrew, R., & Homer, N. Z. M. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150234 · Cited by 6
Etiopathogeny of Primary Adrenal Hypercortisolism
Vélayoudom‐Céphise, F., Haissaguerre, M., & Tabarin, A. (2016) · Frontiers of hormone research · doi:10.1159/000443863 · Cited by 6
How Useful is Urinary-Free Cortisol in the Clinic?
Sheriff, N., & McCormack, A. I. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0311 · Cited by 6
Plant Natural Compounds in the Treatment of Adrenocortical Tumors
Manso, J., Sharifi‐Rad, J., Zam, W., Fokou, P. V. T., Martorell, M., & Pezzani, R. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5516285 · Cited by 6
Integration of molecular imaging in the personalized approach of patients with adrenal masses
Lorusso, M., RUFINI, V., CREA, C. D., Pennestrì, F., BELLANTONE, R., & RAFFAELLI, M. (2022) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.22.03449-5 · Cited by 6
Wong, C.-L., Fok, C.-K., Chan, Y., Tam, V. H.-K., & Fung, L. M. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/7395050 · Cited by 6
Urinary steroid metabolites in a case of florid Ectopic Cushing’s syndrome and clinical correlations
Kyriacou, A., Stępień, K. M., & Issa, B. G. (2016) · HORMONES · doi:10.14310/horm.2002.1695 · Cited by 6
Perna, V., Taylor, N., Dorota Dworakowska, B., Schulte, K., Aylwin, S. J. B., Al‐Hashimi, F., & Díaz‐Cano, S. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12458 · Cited by 6
Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go
Anyfanti, P., Nikolaidou, B., & Gkaliagkousi, Ε. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30341-7 · Cited by 6
A multi-cancer metamaterial biosensor: refractive index-based identification of malignant cells
Mellak, N., Moulfi, B., & Aliouar, T. (2025) · Optical and Quantum Electronics · doi:10.1007/s11082-025-08436-1 · Cited by 5
The molecular genetics of adrenal cushing
Vaduva, P., & Bertherat, J. Y. (2024) · HORMONES · doi:10.1007/s42000-024-00608-0 · Cited by 5
Self-citationHan, M.-M., Cao, X.-M., Liu, Z., Zhang, Y., & Liu, Y. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i3.100580 · Cited by 5
Lee, K., Goh, J., Jang, J. Y., Hwang, J., Kwak, J., Kim, J.-H., & Eom, K. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1126165 · Cited by 5
Steroid profiling in adrenal disease
Mu, D., Sun, D., Qian, X., Ma, X., Qiu, L., Cheng, X., & Yu, S. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117749 · Cited by 5
Nakano, Y., Yokomoto‐Umakoshi, M., Nakatani, K., Umakoshi, H., Nakao, H., Fujita, M., Kaneko, H., Iwahashi, N., Ogasawara, T., Fukumoto, T., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae140 · Cited by 5
Current approach of primary bilateral adrenal hyperplasia
Delivanis, D. A., Vassiliadi, D. A., & Tsagarakis, S. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000725 · Cited by 5
The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors
Chortis, V. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02869-9 · Cited by 5
Plasma steroid profiles before and after ACTH stimulation test in healthy horses
Kirchmeier, A., van Herwaarden, A. E., van der Kolk, J. H., Sauer, F. J., & Gerber, V. (2019) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2019.106419 · Cited by 5
Challenges in Neural Computation
Hammer, B. (2012) · Künstliche Intell. · doi:10.1007/s13218-012-0209-0 · Cited by 5
Inferring Feature Relevances From Metric Learning
Schulz, A., Mokbel, B., Biehl, M. L., & Hammer, B. (2015) · IEEE Symposium Series on Computational Intelligence (SSCI) · doi:10.1109/ssci.2015.225 · Cited by 5
Self-citationChortis, V., Johal, N. J., Bancos, I., Evans, M., Skordilis, K., GUEST, P. J., Cullen, M. H., Porfiri, E., & Arlt, W. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0542 · Cited by 5
Self-citationElhassan, Y., Appenzeller, S., Landwehr, L., Lippert, J., Popat, D., Gilligan, L. C., Abdi, L., Goh, E., Díaz‐Cano, S. J., Kircher, S., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae106 · Cited by 4
Self-citation
Metadata
- Authors
- Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., Porfiri, E., Opocher, G., Bertherat, J., Mantero, F., Allolio, B., Terzolo, M., Nightingale, P., Shackleton, C. H. L., Bertagna, X., Fassnacht, M., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- University of Groningen (NL)
- University of Würzburg (DE)
- Inserm (FR)
- University of Padua (IT)
- Department of Endocrinology (R.L., J.B., X.B.), INCa-COMETE, Cochin Hospital, Institut Cochin, Institut National de la Santé et de la Recherche Médicale Unité 1016, René Descartes University, 75006 Paris, France
- University of Turin (IT)
- National Health Service (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-12-01
- Volume
- 96
- Issue
- 12
- Pages
- 3775-3784
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3232629
- OpenAlex
- W1991016861
- Cited by
- 458
- References
- 38
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 31 · 2023: 26 · 2022: 31 · 2021: 28 · 2020: 41 · 2019: 48 · 2018: 35 · 2017: 30 · 2016: 30 · 2015: 41 · 2014: 24 · 2013: 21 · 2012: 21
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by-nc)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Padua Research Archive (University of Padova) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0508-10356)
- European Commission (259735)
- European Science Foundation
- Medical Research Council (G0801473)
- European Social Fund
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal adenoma, adrenal incidentaloma, steroid profiling, machine learning biomarkers, benign versus malignant differentiation
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Cortex Neoplasms, Adult, Aged, Aged, 80 and over, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Mass Spectrometry, Biomarkers, Adrenocortical Adenoma, Adrenocortical Carcinoma, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
